Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

The Link Between Big Pharma and the Supplement Industry

Posted on July 28th, 2017 by in Pharma R&D

When the FDA updated some of its guidelines around dietary supplements last year, many critics of the supplement (or “nutraceutical”) business were pleased to see a bit more regulation in an industry that enjoys surprisingly little oversight. Continue reading “The Link Between Big Pharma and the Supplement Industry” »

Biosimilars Development & its Future

Posted on July 10th, 2017 by in Pharma R&D

The pharmaceutical industry had really been quite optimistic as of late regarding regulatory overhaul and getting rid of the ever-present ‘red tape’ within the regulatory body in the US, and the FDA had shown a very positive response towards getting biosimilars approved. Continue reading “Biosimilars Development & its Future” »

Advantages and Challenges of Using Social Media for Pharma R&D

Posted on July 7th, 2017 by in Pharma R&D

Social media is a force to be reckoned with in modern society. Over the last decade, it has changed the way we interact with friends and family, consumes news and entertainment, and do business.

Continue reading “Advantages and Challenges of Using Social Media for Pharma R&D” »

The Election 2016: A Scientist Reflects

Posted on November 15th, 2016 by in Pharma R&D

Like many of my science colleagues in the U.S., I was gobsmacked by the outcome of the presidential election last Tuesday. With some exceptions, most of my academic and industry colleagues were supporting the Clinton campaign in the general election. Continue reading “The Election 2016: A Scientist Reflects” »

  1. 1
  2. 2